The trend for the timing of initial marketing authorization applications (MAAs) to be less predictable is slowly reversing ...
Enterprise Management Associates (EMA™), a leading IT research and consulting firm, today announced it will host a webinar, ...
European authorities have recommended changes to the regulatory framework to keep pace with the progress of the ...
Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics ...
The reform grants eight years of regulatory data and market protection, with extensions for drugs addressing unmet needs. EMA's procedures will be streamlined, reducing assessment times and ...
The European Medicines Agency (EMA) announced on Jan. 10, 2025 that it is prepared for the implementation of the health technology assessment regulation (HTAR) that comes into effect on Jan. 12, 2025 ...